Genetic risk for schizophrenia is tied to thinner retinas, suggesting retinal scans could aid early detection and treatment.

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

US FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system: Galway, Ireland Monday, April 21, 2025, ...

AI technologies hold immense potential to transform diabetes self-care by improving monitoring, enabling personalized ...

Has the recent Tuberculosis outbreak in Kansas got you worried about catching TB? Learn about the top symptoms to look out ...

Medtronic plc has announced the U.S. Food and Drug Administration (FDA) has approved the Simplera Sync sensor for use with ...

While Type 5 diabetes remains a concept rather than a defined clinical entity the underlying message is clear effectively ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

Leidos invests in Pitt AI initiativeLeidos inked a $10 million investment and five-year collaboration to enhance the ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...

Medtronic has received clearance from the U.S. Food and Drug Administration for the Simplera Sync sensor for use with the MiniMed 780G system.